Comprehensive management of locally advanced breast cancer

Cancer

Volumn 66, Issue 14 S, 1990, Pages 1387-1391

  Hortobagyi, G N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; BREAST CANCER; CONFERENCE PAPER; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SURVIVAL;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMPREHENSIVE HEALTH CARE; FEMALE; HUMAN;

EID: 0024991432     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19900915)66:14+<1387::AID-CNCR2820661414>3.0.CO;2-I     Document Type: Article

References (49)

1. Clinical classification of the stage of advancement of breast carcinoma.
2. Stoker TAM. The place of surgical excision in the management of locally advanced breast cancer
3. Management of locally advanced breast cancer (stage III): A review
4. Inflammatory carcinoma.
5. Inflammatory carcinoma of the breast: A correlation of clinical, radiologic and pathologic findings
6. Inflammatory carcinoma of the breast
7. The inoperability of inflammatory carcinoma of the breast
8. A prospective trial of the TNM classification of breast cancer by the Regional Cancer Treatment Centres in Ontario
9. Evaluation of TNM classification of carcinoma of the breast
10. Sistema TNM 1978 en cancer de mama: Propuesta de modification
11. Factores pronosticos en el cancer de mama.
12. Special therapeutic problems
13. Treatment of metastases.
14. 4) breast cancer
15. Combined chemotherapy and radiotherapy for locally advanced breast cancer
16. Multimodal treatment for locally advanced breast cancer: Results of chemotherapy‐radiotherapy versus chemotherapy‐surgery
17. Multimodal treatment of locoregionally advanced breast cancer
18. Initial chemoimmunotherapy in inflammatory carcinoma of the breast
19. Management of inflammatory carcinoma of the breast: A combined modality approach
20. Pathological assessment of response to induction chemotherapy in breast cancer
21. Aggressive combined modality therapy for advanced local‐regional breast carcinoma
22. Neoadjuvant (preoperative) chemotherapy for breast cancer
23. Neo‐adjuvant chemotherapy in the conservative management of breast cancers: Study on 205 patients.
24. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy
25. Concurrent chemotherapy and radiotherapy for nonmetastatic, stage IV breast cancer: A pilot study by the Southeastern Cancer Study Group
26. 4 breast cancer: Factors affecting results in combined modality treatments
27. An analysis of the role of radiotherapy alone and in combination with chemotherapy and surgery in the management of advanced breast cancer
28. Adjuvant chemo‐ and hormonal therapy in locally advanced breast cancer: A randomized clinical study
29. Management of nonresectable locally advanced (stage III) breast cancer: An ECOG trial
30. Neo‐adjuvant chemotherapy for stage III breast cancer: 5 year report of CALGB 7784.
31. Essai pilote de chimiotherapie neo‐adjuvants dans le cancer.
32. Results of neoadjuvant chemotherapy (NEOAD CHEM) with or without hormonotherapy and external and interstitial radiation in 98 locally advanced breast cancer
33. Treatment of locally advanced breast cancer (LABC) using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery (Abstr)
34. Preoperative chemotherapy in the treatment of inflammatory breast cancer.
35. Resultats du traitement des cancers inflammatoires du sein par une association therapeutique comportant une chimiotherapie initiale.
36. Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave‐Roussy
37. Adjuvant CMF in breast cancer: Comparative 5‐year results of 12 versus 6 cycle
38. Postmastectomy adjuvant chemotherapy with or without radiation therapy in women with operable breast cancer and positive axillary lymph nodes: The South‐eastern Cancer Study Group experience
39. Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer
40. Combined therapy of stage III adenocarcinoma of the breast (Abstr)
41. Adjuvant therapy of breast cancer: The Southwest Oncology Group experience
42. Ten‐year results of FAC adjuvant chemotherapy trial in breast cancer
43. Meeting highlights: Adjuvant therapy for breast cancer
44. Adjuvant chemotherapy of breast cancer: The consensus development conference revisited
45. High‐dose intensification for stage IV hormonally‐refractory breast cancer
46. Growth factors and cancer